48,860
edits
(→Images: Added low grade pancreatic neuroendocrine tumor) |
|||
Line 46: | Line 46: | ||
**[[Neurofibromatosis type 1]].<ref name=pmid15249710>{{Cite journal | last1 = Alexakis | first1 = N. | last2 = Connor | first2 = S. | last3 = Ghaneh | first3 = P. | last4 = Lombard | first4 = M. | last5 = Smart | first5 = HL. | last6 = Evans | first6 = J. | last7 = Hughes | first7 = M. | last8 = Garvey | first8 = CJ. | last9 = Vora | first9 = J. | title = Hereditary pancreatic endocrine tumours. | journal = Pancreatology | volume = 4 | issue = 5 | pages = 417-33; discussion 434-5 | month = | year = 2004 | doi = 10.1159/000079616 | PMID = 15249710 }}</ref> | **[[Neurofibromatosis type 1]].<ref name=pmid15249710>{{Cite journal | last1 = Alexakis | first1 = N. | last2 = Connor | first2 = S. | last3 = Ghaneh | first3 = P. | last4 = Lombard | first4 = M. | last5 = Smart | first5 = HL. | last6 = Evans | first6 = J. | last7 = Hughes | first7 = M. | last8 = Garvey | first8 = CJ. | last9 = Vora | first9 = J. | title = Hereditary pancreatic endocrine tumours. | journal = Pancreatology | volume = 4 | issue = 5 | pages = 417-33; discussion 434-5 | month = | year = 2004 | doi = 10.1159/000079616 | PMID = 15249710 }}</ref> | ||
===Classification=== | ===WHO classification of 2017=== | ||
Five categorizes:<!-- https://www.esp-congress.org/fileadmin/user_upload/Congress_2016/IAP_ESP_Presentations/Mon/0830-1200/SY-02/SY-02-004-Kl%C3%B6ppel-Update%20of%20WHO%20classification%20of%20endocrine%20pancreatic%20tumours.pdf --> | |||
*NET1. | |||
*NET2. | |||
*NET3. | |||
*Neuroendocrine carcinoma. | |||
*[[MiNEN]]. | |||
===Classification by product=== | |||
Based on peptide produced in the pancreatic islets: | Based on peptide produced in the pancreatic islets: | ||
#Glucagon from alpha cells ([[glucagonoma]]). | #Glucagon from alpha cells ([[glucagonoma]]). |
edits